NSW Health will spend $38.7 million putting ambient artificial intelligence scribes in the hands of up to 6,000 clinicians across the state’s public hospitals, in one of the largest announced deployments of clinical documentation AI in Australia.
The commitment, drawn from the 2026-27 NSW Budget, was first reported by The Medical Republic on 1 July. It sits inside a broader “future of healthcare” package aimed at easing pressure on clinicians and improving patient flow, according to the NSW Budget health overview.
Ambient scribes work by listening to a consultation and drafting the clinical note automatically, so a doctor or nurse does not have to type it up afterwards. The technology has spread quickly through Australian general practice over the past two years. Putting it into the public hospital system at this scale is a different order of ambition.
What the money buys
The $38.7 million is earmarked for a statewide rollout of scribe technology to as many as 6,000 clinicians, alongside four AI proof-of-concept projects in diagnostics, radiology, clinical decision-making and patient flow. NSW Health has framed the scribe deployment as a way to cut the administrative load that eats into clinical time and contributes to burnout.
Notably, the department has not said which product it will use. NSW Health has not disclosed whether a supplier has been selected, which scribe platform will be deployed, or when the statewide rollout will begin, per The Medical Republic. Planning, “including evaluation of potential solutions”, is being guided by the NSW Health AI Framework, the department said.
That reticence is telling. A commitment of this size, announced before a vendor is named, reads as a signal of intent as much as a procurement. It also leaves room for a competitive tender, which is where the money gets interesting for the local industry.
Governance came first
The scribe funding lands on top of a governance layer NSW built earlier this year. The NSW Health AI Framework was published in February 2026, setting out a risk-based approach to using AI across the public health system, according to the Agency for Clinical Innovation’s AI Framework resources and its Clinician Connect briefing.
The framework is the work of the NSW Health AI Taskforce, co-chaired by Dr Jean-Frederic Levesque, chief executive of the Agency for Clinical Innovation, and Richard Taggart, chief executive of eHealth NSW, per the same ACI materials. It spans seven priority areas, including consumers, workforce, privacy and security, safety, ethics and quality, and industry, and is paired with an AI Advisory Service that clinicians can consult before adopting a tool.
Sequencing matters here. NSW put the rules in place before it put the cheque on the table, which is close to the opposite of how the first wave of GP-clinic scribe adoption played out, where clinicians often signed up for consumer-grade tools well ahead of any institutional guidance on privacy, consent or record-keeping. For a public system holding sensitive patient data at scale, that order of operations is the point.
Why it matters for Australia
This is one of the biggest public-sector AI healthcare commitments yet announced in Australia, and it marks a shift in where ambient documentation is headed. Until now, the technology’s centre of gravity has been the GP clinic and the private specialist rooms. A statewide hospital deployment moves it into emergency departments, outpatient clinics and inpatient wards, environments with far more complex consent, integration and medico-legal demands.
It also sets a funding and governance precedent other states will be watching. NSW is the largest health system in the country by population, and a $38.7 million line item attached to a published AI framework gives health ministers elsewhere a template to point to. If the rollout demonstrably returns clinician time, expect Victoria, Queensland and Western Australia to face pressure to match it.
The most immediate stakes, though, are commercial. Australia has grown two globally competitive scribe companies, and both are already inside the hospital market. Melbourne-based Heidi Health is used at scale by Monash Health and the Queensland Children’s Hospital, according to The Medical Republic, while Lyrebird Health has been trialled by more than 70 Gold Coast Health specialists in outpatient settings. A NSW tender at this scale is a marquee reference customer, and losing it to an overseas platform or an embedded electronic medical record feature would sting.
That last point is the structural question hanging over the sector. As Health Services Daily has reported, every major medical-record vendor is now weighing whether ambient documentation should be a built-in platform feature rather than a standalone product. NSW’s choice, buy a dedicated scribe or lean on what its record systems can bundle, will send a signal about which model wins in large hospital settings.
What to watch next
The open questions are the ones NSW Health has not yet answered: who supplies the technology, on what timeline, and how the department measures success. Time returned to clinicians is the headline metric everyone will cite, but note accuracy, patient consent workflows and integration with existing hospital systems will determine whether 6,000 clinicians actually keep using it.
For a technology that arrived in Australian healthcare almost entirely through the front door of general practice, a formal, framework-governed hospital rollout is a coming-of-age moment. The tender, whenever it lands, will be one of the most closely watched health-tech procurements in the country.
Sources: The Medical Republic, NSW Budget 2026-27 (Health), ACI NSW Health AI Framework, ACI Clinician Connect, The Medical Republic (Heidi), The Medical Republic (scribe wars), Health Services Daily.
